{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:08:25Z","timestamp":1789373305044,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030798","name":"Digital Futures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030798","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The SciLifeLab & Wallenberg Data Driven Life Science Program","award":["KAW 2024.0159"],"award-info":[{"award-number":["KAW 2024.0159"]}]},{"name":"The SciLifeLab & Wallenberg Data Driven Life Science Program","award":["KAW 2024.0159"],"award-info":[{"award-number":["KAW 2024.0159"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"crossref","award":["Dnr 2025-02061"],"award-info":[{"award-number":["Dnr 2025-02061"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prostatacancer F\u00f6rbundet"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Risk stratification in primary prostate cancer remains heavily reliant on clinicopathological criteria that frequently miss the heterogeneity underlying early aggressive disease. We present a novel machine learning non-linear prognostic framework encoding somatic copy-number alterations and biological information associated with gene products, along with an integrative multi-omics approach including epigenomics and transcriptomics into a patient-specific biological network. Applied to the TCGA-PRAD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009498), our weighted graph-based feature selection and LASSO-Cox model identified\n                    <jats:italic>ZNF268<\/jats:italic>\n                    as a master regulator gene, in which the hypermethylation of its promoter region is linked to a distinct oncogenic transition exclusive to Low\/Intermediate-risk disease. Post-hoc analysis of Low-\n                    <jats:italic>ZNF268<\/jats:italic>\n                    tumors showed a distinct somatic landscape enriched for driver mutations and predicted sensitivity to MAPK, ATR, and PI3K\/mTOR inhibitors, providing potential therapeutic vulnerabilities alongside the prognostic signal. Topological network analysis further revealed that\n                    <jats:italic>ZNF268<\/jats:italic>\n                    loss impacts a co-expression rewiring gene network, quantified as a Rewiring Score: associated with Progression-Free Survival in the TCGA-PRAD (HR: 2.79, 95% CI: 1.36\u20135.71,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0049) and Biochemical Recurrence in two external cohorts. By capturing tumors at an active molecular transition state preceding systemic progression, this framework offers a prognostic tool to identify biologically aggressive prostate cancer disease within patients currently undertreated by standard risk criteria.\n                  <\/jats:p>","DOI":"10.1038\/s41746-026-03254-5","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:34:50Z","timestamp":1789371290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel multiomics machine learning signature identifies rapid progression in clinically low risk prostate cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Alexandra","family":"Rafeletou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Kise\u013cova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"3254_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"3254_CR2","first-page":"e70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA: Cancer J. Clin. 76, e70043 (2026).","journal-title":"CA: Cancer J. Clin."},{"key":"3254_CR3","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","volume":"83","author":"A Lundberg","year":"2023","unstructured":"Lundberg, A. et al. The genomic and epigenomic landscape of double-negative metastatic prostate cancer. Cancer Res. 83, 2763\u20132774 (2023).","journal-title":"Cancer Res."},{"key":"3254_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","volume":"23","author":"DE Spratt","year":"2025","unstructured":"Spratt, D. E. et al. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J. Natl. Compr. Canc Netw. 23, 469\u2013493 (2025).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"3254_CR5","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1158\/1078-0432.CCR-22-2567","volume":"28","author":"E Feng","year":"2022","unstructured":"Feng, E. et al. Intrinsic molecular subtypes of metastatic castration-resistant prostate cancer. Clin. Cancer Res. 28, 5396\u20135404 (2022).","journal-title":"Clin. Cancer Res."},{"key":"3254_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82789-7","volume":"14","author":"R Ye","year":"2024","unstructured":"Ye, R. et al. Identification of the shared gene signatures in retinoblastoma and osteosarcoma by machine learning. Sci. Rep. 14, 31355 (2024).","journal-title":"Sci. Rep."},{"key":"3254_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2026.102684","volume":"65","author":"Y Du","year":"2026","unstructured":"Du, Y. et al. Utilization of machine learning algorithms for the identification of the RLN-associated prognostic model and feature biomarkers of RLN-related subtypes in breast cancer. Transl. Oncol. 65, 102684 (2026).","journal-title":"Transl. Oncol."},{"key":"3254_CR8","doi-asserted-by":"publisher","unstructured":"Yu, G. et al. A machine learning-driven framework integrating cell death and senescence signatures for multi-target drug design and immunotherapy optimization in ovarian cancer. npj Precis. Onc https:\/\/doi.org\/10.1038\/s41698-026-01448-4 (2026).","DOI":"10.1038\/s41698-026-01448-4"},{"key":"3254_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer, E. M. et al. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc Netw. 21, 1067\u20131096 (2023).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"3254_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR11","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR12","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2024","unstructured":"Agrawal, A. et al. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 52, D679\u2013D689 (2024).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR13","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","volume":"74","author":"Q Long","year":"2014","unstructured":"Long, Q. et al. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res. 74, 3228\u20133237 (2014).","journal-title":"Cancer Res."},{"key":"3254_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","volume":"613","author":"N Loyfer","year":"2023","unstructured":"Loyfer, N. et al. A DNA methylation atlas of normal human cell types. Nature 613, 355\u2013364 (2023).","journal-title":"Nature"},{"key":"3254_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-020-2559-3","volume":"584","author":"W Meuleman","year":"2020","unstructured":"Meuleman, W. et al. Index and biological spectrum of human DNase I hypersensitive sites. Nature 584, 244\u2013251 (2020).","journal-title":"Nature"},{"key":"3254_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"PCF\/SU2C International Prostate Cancer Dream Team","year":"2018","unstructured":"PCF\/SU2C International Prostate Cancer Dream Team The long tail of oncogenic drivers in prostate cancer. Nat. Genet 50, 645\u2013651 (2018).","journal-title":"Nat. Genet"},{"key":"3254_CR17","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013D961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10331","volume":"7","author":"E Guney","year":"2016","unstructured":"Guney, E., Menche, J., Vidal, M. & Bar\u00e1basi, A.-L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331 (2016).","journal-title":"Nat. Commun."},{"key":"3254_CR19","doi-asserted-by":"publisher","first-page":"76756","DOI":"10.18632\/oncotarget.12525","volume":"7","author":"D Albino","year":"2016","unstructured":"Albino, D. et al. The ETS factor ESE3\/EHF represses IL6, preventing STAT3 activation and expansion of the prostate cancer stem-like compartment. Oncotarget 7, 76756\u201376768 (2016).","journal-title":"Oncotarget"},{"key":"3254_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00109-014-1160-3","volume":"92","author":"S Hahn","year":"2014","unstructured":"Hahn, S. & Hermeking, H. ZNF281\/ZBP-99: a new player in epithelial\u2013mesenchymal transition, stemness, and cancer. J. Mol. Med 92, 571\u2013581 (2014).","journal-title":"J. Mol. Med"},{"key":"3254_CR21","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. In Proc. 31st International Conference on Neural Information Processing Systems, 4768\u20134777 (Curran Associates Inc., Red Hook, NY, USA, 2017)."},{"key":"3254_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/1521654031000110208","volume":"55","author":"Y Sun","year":"2003","unstructured":"Sun, Y., Gou, D., Liu, H., Peng, X. & Li, W. The KRAB domain of zinc finger gene ZNF268: a potential transcriptional repressor. IUBMB Life 55, 127\u2013131 (2003).","journal-title":"IUBMB Life"},{"key":"3254_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105428","volume":"299","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient interferon signaling. J. Biol. Chem. 299, 105428 (2023).","journal-title":"J. Biol. Chem."},{"key":"3254_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"3254_CR25","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s00018-018-2799-7","volume":"75","author":"M-S Wegner","year":"2018","unstructured":"Wegner, M.-S. et al. UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells. Cell. Mol. Life Sci. 75, 3393\u20133410 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"3254_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","volume":"6","author":"K Ellrott","year":"2018","unstructured":"Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271\u2013281.e7 (2018).","journal-title":"Cell Syst."},{"key":"3254_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"3254_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314\u2013316 (2017).","journal-title":"Nat. Biotechnol."},{"key":"3254_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"3254_CR30","doi-asserted-by":"crossref","unstructured":"Korotkevich, G. et al. Fast Gene Set Enrichment Analysis http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/060012 (2016).","DOI":"10.1101\/060012"},{"key":"3254_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"3254_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"3254_CR33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"3254_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinforma. 11, 587 (2010).","journal-title":"BMC Bioinforma."},{"key":"3254_CR35","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon, M. et al. DGIdb 5.0: rebuilding the drug\u2013gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 52, D1227\u2013D1235 (2024).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR36","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808\u2013D815 (2013).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR37","doi-asserted-by":"publisher","first-page":"D1057","DOI":"10.1093\/nar\/gku1113","volume":"43","author":"RP Huntley","year":"2015","unstructured":"Huntley, R. P. et al. The GOA database: Gene Ontology annotation updates for 2015. Nucleic Acids Res. 43, D1057\u2013D1063 (2015).","journal-title":"Nucleic Acids Res."},{"key":"3254_CR38","doi-asserted-by":"publisher","unstructured":"Liu, L.-P., Dietterich, T. G., Li, N. & Zhou, Z.-H. Transductive Optimization of Top-k Precision. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1510.05976 (2015).","DOI":"10.48550\/arXiv.1510.05976"},{"key":"3254_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i01","volume":"106","author":"JK Tay","year":"2023","unstructured":"Tay, J. K., Narasimhan, B. & Hastie, T. Elastic net regularization paths for all generalized linear models. J. Stat. Softw. 106, 1\u201331 (2023).","journal-title":"J. Stat. Softw."},{"key":"3254_CR40","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/sim.4780132307","volume":"13","author":"PJM Verweij","year":"1994","unstructured":"Verweij, P. J. M. & Van Houwelingen, H. C. Penalized likelihood in Cox regression. Stat. Med. 13, 2427\u20132436 (1994).","journal-title":"Stat. Med."},{"key":"3254_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"3254_CR42","doi-asserted-by":"crossref","unstructured":"SEQC\/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat. Biotechnol. 32, 903\u2013914 (2014).","DOI":"10.1038\/nbt.2957"},{"key":"3254_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"3254_CR44","doi-asserted-by":"publisher","unstructured":"Therneau, T. M. survival: Survival Analysis. 3.8-6 https:\/\/doi.org\/10.32614\/CRAN.package.survival (2001).","DOI":"10.32614\/CRAN.package.survival"},{"key":"3254_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"3254_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03254-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:47:52Z","timestamp":1789372072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3254"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-03254-5","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L. is an editorial board member of Scientific Reports (Sci Rep) as part of Springer Nature\u2019s publication. A.L. was not involved in, and had no influence over, the review of, or decision related to, this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"702"}}